Treatment of HCV genotype 2 with sofosbuvir and ribavirin results in lower SVR rates in real life than expected from clinical trials

Authors
Publication date
1 January 2016
Publisher
Wiley Interscience

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    Publikationsserver der RWTH Aachen University

    redirect
    oaioai:publications.rwth-aachen.d...
    Last time updated on 04/11/2017

    RWTH Publications

    redirect
    oaioai:publications.rwth-aachen.d...
    Last time updated on 18/04/2020